Chapter 780

Li Zhangzhen rushed to Huarui laboratory with Gan Hu, the general manager of Huarui pharmaceutical, accompanied by the company's lawyers and the full set of documents of the newly established Huarui pharmaceutical.

Gan Hu was dug up by Li Zhangzhen in Hong Kong. As far as his resume is concerned, it's really poor. The most conspicuous work experience is just a few years of workshop experience in the factory of a well-known pharmaceutical company and a few years of wasted time in the office

Li Zhangzhen also knew that the person he chose was not very satisfactory, so he could only explain to one side: "time is tight, We're a new company, and we don't have the right people under our headhunters. "

"How much is the salary?"

"Fifteen thousand yuan a month. If you want to work in the mainland, you have to add another three thousand yuan and get two round-trip air tickets every year." Li Zhangzhen added: "in fact, if we set up a pharmaceutical factory in Hong Kong, it would be better to recruit more people..."

"This is not the time for the workers trained by Xijie factory." Yang Rui immediately vetoed Li Zhangzhen's proposal and said, "let's use Gan Hu first. At that time, we will see his level. You can continue to supervise the work of Huarui pharmaceutical and report to me at any time."

"Don't worry. I'll take care of it. " Li Zhangzhen nodded heavily. Yang Rui's energy has always been focused on scientific research, which gives him great discretionary power in the company. Li Zhangzhen knows in his heart that this rare window period will not last too long, just like Yue Ting, a barrister, is gradually eroding the company's original small lawyer's territory. In the future, Huarui will be able to recruit more and more professional managers, If Li Zhangzhen wants to keep his position, he has to work harder.

And trust is his biggest asset.

"Ask Gan Hu to come in for tea." Yang Rui returned to his teahouse and opened a package of Zhengshan Xiaozhong, while slowly boiling water.

For a while, Gan Hu with curiosity, into the sharp laboratory.

This is a thin, middle-aged man, a little like the real tiger in Wu Song by Yang Rui, and the small one is like a leopard.

"Come and have tea." Yang Rui said, "I'm the head of Huarui laboratory. I'm from mainland China. I'm also in charge of the preparation of Huarui pharmaceutical. What Huarui pharmaceutical is going to do next is desferridone, which I developed. "

Yang Rui does not say that he is the big boss behind him, but still let Gan Hu understand that he is his superior.

Gan Hu and Yang Rui shook hands politely, sat down on the opposite stool and said with a smile, "I know you have the right to decide."

"Now there are, and then there are, so you have to work with me, not the other way around."

Gan Hu looks at Li Zhangzhen, who nods to confirm.

"I see." Although Gan Hu is not reconciled, but also recognized. There are two kinds of internal structure of pharmaceutical companies, one is that the laboratory cooperates with the factory, the other is that the factory cooperates with the laboratory.

Yang Rui's words are tantamount to saying that Huarui Pharmaceutical Co operates with the laboratory. Although Gan Hu doesn't feel comfortable, he can only agree.

Unlike ordinary people's intuition, most pharmaceutical companies are actually laboratories cooperating with factories, especially domestic and Hong Kong pharmaceutical companies.

When you think about it, it's easy to understand that most of the pharmaceutical companies in the world, including those in China, Hong Kong and the US imperialism, are generic drug companies. The difficulties faced by generic drug companies are different from those faced by original drug companies. The difficulties faced by original drug companies usually lie in what structure of compounds can cure diseases and why, while the difficulties faced by generic drugs usually lie in how to make this structure of compounds.

The rest, the original drug company has completed for the generic drug company.

Generic drug is the Shanzhai company in pharmaceutical enterprises. Although the strict system of drug protection enables original drug companies to get drug monopoly and recover costs in a few years, generic drug companies can also make use of this time to make generic research.

Compared to pharmacokinetic and clinical trials, it's just too easy to synthesize compounds.

Take India as an example, their compulsory patent system can produce drugs almost immediately after the court has issued the order of compulsory patent. This is not because their laboratories are stronger than those in Europe and America, but because the key of pharmaceutical industry is not drug synthesis.

Gan Hu's previous companies were all generic drug companies, and he had not contacted the original drug company with the laboratory as the core. At this time, he could only keep silent and wait for the situation to be known later.

However, Yang Rui's request is not only that. He introduced the situation of deferonone to Gan Hu and Li Zhangzhen. Before their excitement faded, he said, "I have contacted Jielikang. Your next task is to seize the time to cooperate with Jielikang."

Gan Hu's face changed: "Jericho of England?""That's right."

"You want to sell deferonone to the British?" Gan Hu asked naturally. Jielikang is a multinational pharmaceutical enterprise, and its scale is also in the forefront of original pharmaceutical enterprises. Such a company has little comparability with the newly established Huarui pharmaceutical, and hardly any cooperation.

Yang Rui thought about it: "my intention is to use the resources of Jericho to train the team and let you get familiar with the whole process of drug declaration. Of course, if Jericho is willing to offer a good price to buy the patents of iron ketone, I think it's OK. Next, Huarui pharmaceutical will do the next project."

In Yang Rui's eyes, deferoxane is just a rare drug that doesn't make a lot of money. There is also deferoxamine competition, which is not profitable. In fact, Yang Rui doesn't want to make money by deferoxane. Solving the plight of thalassemia patients is the first priority. In addition, if jericham is interested, This kind of large pharmaceutical company can promote the listing of deferonone more quickly and reduce the production cost.

Gan Hu was full of doubts, and the most important thing was to say: "is Jericho willing to cooperate with us? Isn't it a direct acquisition? "

"The relationship between Huarui and jerichon is quite special. Jerichon has agreed to cooperate." Yang Rui doesn't care about this problem.

If Jielikang used to cheat customers, since Yang Rui made the additive of coenzyme Q10, it is meaningless to cheat customers.

It should be said that Jielikang did not chase Yang Rui's ass for coenzyme Q10 additive, which is the result of their suppressing impulse and bureaucratic explosion.

Of course, the most important thing is that jerichon is negotiating with its Japanese and Norwegian competitors at the same time.

When Yang Rui took the absolute initiative, many companies in three countries did not rush on like flies smelling meat. To be exact, at the beginning, when Yang Rui's catalyst formula was still fresh meat, many companies rushed on. The Japanese and Norwegians even intercepted Yang Rui at the airport, trying to lower the price, Get this lucrative catalyst patent.

But after Yang Rui showed a big appetite, all the companies restrained their impulses and began to negotiate with each other instead.

This is also a common scene in pharmaceutical groups. Pharmaceutical companies are always one, especially the large original pharmaceutical companies. They will not easily negotiate in the downwind. They always try their best to seize the right to speak.

For Yang Rui's catalyst formula, if according to the bottom line of jerichon, 12 million US dollars plus 2% of the dividend right is won, jerichon will not hesitate to pay and beat the Japanese company with it.

But Yang Rui's appetite has exceeded 5% of the sales dividend, which is not acceptable to Jielikang.

If the formulation of a mere catalyst does not contribute or participate in the operation, it will take 5% of the income of the whole coenzyme Q10 industry, which is comparable to tax.

Several pharmaceutical companies would rather negotiate with each other, no matter whether they can come to a conclusion, but at least they can keep down the price on Yang Rui.

Anyway, we can still maintain the current situation without catalyst.

Two months, for large pharmaceutical companies, can be regarded as an instant.

But for the individual, this is suffering.

Even Yang Rui can't help it.

But he can't ask Jericho directly, so as not to feel guilty.

It's more euphemistic to try out the cooperation of "deferonone".

Frankie, who came in a hurry, could not even say whether Yang Rui was really trying.

After all, it is well known that pharmaceutical companies such as Jericho are deeply awed by the difficulties in the development of original drugs. Even the world's leading pharmaceutical companies are not able to produce new drugs every year, especially the non improved pure original drugs, which are extremely rare. Every successful development and every successful listing, Even the success of each phase of clinical trials means that hundreds of high paid jobs are vacant.

If Yang Rui made an original medicine just for the sake of exploration, it would be nonsense.

Frankie didn't believe it himself.

When he came to Huarui laboratory, Frankie simply looked over Yang Rui's experimental records, but he had to believe it and said, "I don't quite understand what you do, but I have done four experiments to complete the synthesis. Is it a little too simple?"

"That's because the difficult part hasn't started yet. I'd like to ask Jielikang to cooperate with me. Are you willing?"

"I can make a phone call. I don't have the right to decide, but if it does have the effect you said, I think it's OK." Frankie looked at Yang Rui under his white coat with the expression of Superman and turned to make a phone call.……